With oncology now the largest cost center for health plans, experts at the Academy of Managed Care Pharmacy (AMCP) 2026 ...

Hayley Knollman, MD, explains how ctDNA and genomic testing impact ER-positive metastatic breast cancer care, guiding ...

FDA is encouraging supplemental NDAs for TRT to treat low libido in idiopathic hypogonadism, reflecting preliminary ...

High co-payments for potentially curative cell and gene therapies create avoidable access barriers; value-based insurance ...

At AMCP 2026, Daryl Pritchard, PhD, highlighted fragmentation, evidence gaps, and decision support needs limiting precision ...

The July 2026 advisory review could reopen compounding pathways for peptides previously curtailed in 2023 over immunogenicity ...

Metabolic disease is reshaping care delivery and costs, with experts at the Academy of Managed Care Pharmacy (AMCP) 2026 ...

The end of 2025 saw the expiration of the enhanced premium subsidies under the Affordable Care Act (ACA) after Congress was ...

Kelsea Aragon, PharmD, highlights the role of long-acting HIV therapies like lenacapavir and cabotegravir in improving ...

In addition to the models, Taddei-Allen also pointed out the overall shift in employer plan drug costs, shifting more of the ...

Managed care organizations must move beyond early, low-risk artificial intelligence (AI) use to strategically governed, ...

The American Journal of Managed Care® spoke with Adam Colborn, JD, associate vice president of congressional affairs at AMCP.